首页 > 最新文献

REC Interventional Cardiology最新文献

英文 中文
Tratamiento percut�neo de un drenaje venoso pulmonar an�malo parcial con drenaje dual. �C�mo lo har�a? 双引流部分不良肺静脉引流经皮治疗。你要怎么做呢?
Q2 Medicine Pub Date : 2023-02-07 DOI: 10.24875/recic.m22000351
Felipe Hernández Hernández
{"title":"Tratamiento percut�neo de un drenaje venoso pulmonar an�malo parcial con drenaje dual. �C�mo lo har�a?","authors":"Felipe Hernández Hernández","doi":"10.24875/recic.m22000351","DOIUrl":"https://doi.org/10.24875/recic.m22000351","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136252265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Papel del bal�n farmacoactivo en el tratamiento de la trombosis muy tard�a de stent 药物活性球在治疗晚期支架血栓形成中的作用
IF 1.4 Q2 Medicine Pub Date : 2023-01-23 DOI: 10.24875/recic.m22000357
J. Valencia, Francisco Torres-Saura, Fernando Torres-Mezcua, Pascual Bordes, Javier Pineda y, J. M. Ruiz-Nodar
{"title":"Papel del bal�n farmacoactivo en el tratamiento de la trombosis muy tard�a de stent","authors":"J. Valencia, Francisco Torres-Saura, Fernando Torres-Mezcua, Pascual Bordes, Javier Pineda y, J. M. Ruiz-Nodar","doi":"10.24875/recic.m22000357","DOIUrl":"https://doi.org/10.24875/recic.m22000357","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46379067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efecto de clase en el TAVI: ha llegado la hora de saber si son todos iguales TAVI的阶级效应:是时候知道他们是否都一样了
IF 1.4 Q2 Medicine Pub Date : 2023-01-20 DOI: 10.24875/recic.m22000358
Cristóbal A. Urbano-Carrillo
{"title":"Efecto de clase en el TAVI: ha llegado la hora de saber si son todos iguales","authors":"Cristóbal A. Urbano-Carrillo","doi":"10.24875/recic.m22000358","DOIUrl":"https://doi.org/10.24875/recic.m22000358","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47538656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diferencias regionales en la atenci�n al IAMCEST en Espa�a. Datos del Registro de C�digo Infarto ACI-SEC 西班牙对IAMCEST关注的地区差异。ACI-SEC心脏病代码寄存器数据
IF 1.4 Q2 Medicine Pub Date : 2023-01-20 DOI: 10.24875/recic.m22000360
O. Rodríguez-Leor, Ana Belén Cid-Álvarez, Raúl Moreno, X. Rosselló, S. Ojeda, Ana Serrador, R. López-Palop, Javier Martín-Moreiras, José Ramón Rumoroso, Á. Cequier, B. Ibáñez, I. Cruz-González, R. Romaguera, Sergio Raposeiras y, Armando Pérez de Prado
Introduction and objectives: Geographical and organizational differences between different autonomous communities (AC) can generate differences in care for ST-segment elevation myocardial infarction (STEMI). A total of 17 heart attack code programs have been compared in terms of incidence rate, clinical characteristics, reperfusion therapy, delay to reperfusion, and 30-day mortality. Methods: National prospective observational study (83 centers included in 17 infarction networks). The recruitment period was 3 months (April 1 to June 30, 2019) with clinical follow-up at 30 days. Results: 4366 patients with STEMI were included. The incidence rate was variable between different AC (P < .0001), as was gender (P = .003) and the prevalence of cardiovascular risk factors (P < .0001). Reperfusion treatment was primary angioplasty (range 77.5%-97.8%), fibrinolysis (range 0%-12.9%) or no treatment (range 2.2%13.5%). The analysis of the delay to reperfusion showed significant differences (P < .001) for all the intervals analyzed. There were significant differences in 30-days mortality that disappeared after adjusting for clinical and healthcare network characteristics. Conclusions: Large differences in STEMI care have been detected between the different AC, in terms of incidence rate, clinical characteristics, reperfusion treatment, delay until reperfusion, and 30-day mortality. The differences in mortality disappeared after adjusting for the characteristics of the patient and the care network.
引言和目的:不同自治社区(AC)之间的地理和组织差异会导致ST段抬高型心肌梗死(STEMI)的护理差异。共有17个心脏病发作代码程序在发病率、临床特征、再灌注治疗、再灌注延迟和30天死亡率方面进行了比较。方法:全国前瞻性观察性研究(包括17个梗死网络中的83个中心)。招募期为3个月(2019年4月1日至6月30日),临床随访30天。结果:纳入4366例STEMI患者。不同AC的发病率(P<0.0001)、性别(P=.003)和心血管危险因素的患病率(P>0.0001)各不相同。再灌注治疗为原发性血管成形术(范围77.5%-97.8%),纤维蛋白溶解(范围0%-12.9%)或不治疗(范围2.2%13.5%)。对再灌注延迟的分析显示,所有分析的时间间隔都有显著差异(P<.001)。在调整临床和医疗保健网络特征后,30天死亡率有显著差异,但这些差异消失了。结论:在发病率、临床特征、再灌注治疗、延迟再灌注和30天死亡率方面,不同AC之间的STEMI护理存在很大差异。在根据患者和护理网络的特点进行调整后,死亡率的差异消失了。
{"title":"Diferencias regionales en la atenci�n al IAMCEST en Espa�a. Datos del Registro de C�digo Infarto ACI-SEC","authors":"O. Rodríguez-Leor, Ana Belén Cid-Álvarez, Raúl Moreno, X. Rosselló, S. Ojeda, Ana Serrador, R. López-Palop, Javier Martín-Moreiras, José Ramón Rumoroso, Á. Cequier, B. Ibáñez, I. Cruz-González, R. Romaguera, Sergio Raposeiras y, Armando Pérez de Prado","doi":"10.24875/recic.m22000360","DOIUrl":"https://doi.org/10.24875/recic.m22000360","url":null,"abstract":"Introduction and objectives: Geographical and organizational differences between different autonomous communities (AC) can generate differences in care for ST-segment elevation myocardial infarction (STEMI). A total of 17 heart attack code programs have been compared in terms of incidence rate, clinical characteristics, reperfusion therapy, delay to reperfusion, and 30-day mortality. Methods: National prospective observational study (83 centers included in 17 infarction networks). The recruitment period was 3 months (April 1 to June 30, 2019) with clinical follow-up at 30 days. Results: 4366 patients with STEMI were included. The incidence rate was variable between different AC (P < .0001), as was gender (P = .003) and the prevalence of cardiovascular risk factors (P < .0001). Reperfusion treatment was primary angioplasty (range 77.5%-97.8%), fibrinolysis (range 0%-12.9%) or no treatment (range 2.2%13.5%). The analysis of the delay to reperfusion showed significant differences (P < .001) for all the intervals analyzed. There were significant differences in 30-days mortality that disappeared after adjusting for clinical and healthcare network characteristics. Conclusions: Large differences in STEMI care have been detected between the different AC, in terms of incidence rate, clinical characteristics, reperfusion treatment, delay until reperfusion, and 30-day mortality. The differences in mortality disappeared after adjusting for the characteristics of the patient and the care network.","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48551632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Valvuloplastia percut�nea en estenosis a�rtica grave y cr�tica en neonatos: evoluci�n y predictores de mal pron�stico 经皮瓣膜成形术在新生儿重症和重症狭窄中的应用:预后不良的进展和预测因素
Q2 Medicine Pub Date : 2023-01-10 DOI: 10.24875/recic.m22000289
Andrea Freixa-Benavente, Pedro Betrián-Blasco, Gemma Giralt-García, Ferran Rosés-Noguer y, Queralt Ferrer-Menduiña
{"title":"Valvuloplastia percut�nea en estenosis a�rtica grave y cr�tica en neonatos: evoluci�n y predictores de mal pron�stico","authors":"Andrea Freixa-Benavente, Pedro Betrián-Blasco, Gemma Giralt-García, Ferran Rosés-Noguer y, Queralt Ferrer-Menduiña","doi":"10.24875/recic.m22000289","DOIUrl":"https://doi.org/10.24875/recic.m22000289","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136266637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resultados cl�nicos en pacientes sometidos a angioplastia coronaria percut�nea tratados con colchicina 秋水仙素治疗经皮冠状动脉成形术患者的临床结果
IF 1.4 Q2 Medicine Pub Date : 2022-12-30 DOI: 10.24875/recic.m22000353
César E. Soria Jiménez, Jorge Sanz Sánchez, Molly Brooke Levine, F. Hayat, Jerway Chang y, Héctor García-García
Introduction and objectives: The role of inflammation in the pathogenesis of coronary artery disease, and that resulting from percutaneous coronary intervention (PCI) is increasingly recognized, yet the effect of colchicine in attenuating peri-PCI inflammation remains unknown. This meta-analysis investigated the efficacy of colchicine in patients undergoing PCI for secondary prevention of coronary artery disease. Methods: The Web of Science, PubMed, Ovid MEDLINE, Embase, Cochrane Central Register of Controlled Trials and ClinicalTrials. gov databases were searched. Data on studies assessing the efficacy profile of colchicine in patients undergoing PCI were pooled using a random-effects model. Results: In 13 studies of 7414 patients, no differences were observed between patients treated with colchicine compared to those without for all-cause mortality (OR, 1.1; 95%CI, 0.72-1.56; I 2 = 0%), cardiovascular mortality (OR, 0.98; 95%CI, 0.42-2.28; I 2 = 14.2%), myocardial infarction (OR, 0.84; 95%CI, 0.65-1.08; I 2 = 1.4%) or coronary revascularization (OR, 0.64; 95%CI, 0.28-1.42; I 2 = 49.3%). However, patients treated with colchicine had a lower risk of stroke (OR, 0.33; 95%CI, 0.15-0.72; I 2 = 0%).
前言和目的:炎症在冠状动脉疾病发病机制中的作用,以及经皮冠状动脉介入治疗(PCI)引起的炎症,越来越多的人认识到,但秋水仙碱在减轻PCI围期炎症中的作用尚不清楚。这项荟萃分析调查了秋水仙碱在接受PCI的患者中二级预防冠状动脉疾病的疗效。方法:Web of Science, PubMed, Ovid MEDLINE, Embase, Cochrane Central Register of Controlled Trials and ClinicalTrials。检索了政府数据库。评估秋水仙碱对PCI患者疗效的研究数据采用随机效应模型进行汇总。结果:在13项涉及7414例患者的研究中,使用秋水仙碱治疗的患者与未使用秋水仙碱治疗的患者的全因死亡率没有差异(OR, 1.1;95%置信区间,0.72 - -1.56;I 2 = 0%),心血管死亡率(OR, 0.98;95%置信区间,0.42 - -2.28;I 2 = 14.2%),心肌梗死(OR, 0.84;95%置信区间,0.65 - -1.08;I 2 = 1.4%)或冠状动脉血运重建术(or, 0.64;95%置信区间,0.28 - -1.42;i2 = 49.3%)。然而,接受秋水仙碱治疗的患者卒中风险较低(OR, 0.33;95%置信区间,0.15 - -0.72;i2 = 0%)。
{"title":"Resultados cl�nicos en pacientes sometidos a angioplastia coronaria percut�nea tratados con colchicina","authors":"César E. Soria Jiménez, Jorge Sanz Sánchez, Molly Brooke Levine, F. Hayat, Jerway Chang y, Héctor García-García","doi":"10.24875/recic.m22000353","DOIUrl":"https://doi.org/10.24875/recic.m22000353","url":null,"abstract":"Introduction and objectives: The role of inflammation in the pathogenesis of coronary artery disease, and that resulting from percutaneous coronary intervention (PCI) is increasingly recognized, yet the effect of colchicine in attenuating peri-PCI inflammation remains unknown. This meta-analysis investigated the efficacy of colchicine in patients undergoing PCI for secondary prevention of coronary artery disease. Methods: The Web of Science, PubMed, Ovid MEDLINE, Embase, Cochrane Central Register of Controlled Trials and ClinicalTrials. gov databases were searched. Data on studies assessing the efficacy profile of colchicine in patients undergoing PCI were pooled using a random-effects model. Results: In 13 studies of 7414 patients, no differences were observed between patients treated with colchicine compared to those without for all-cause mortality (OR, 1.1; 95%CI, 0.72-1.56; I 2 = 0%), cardiovascular mortality (OR, 0.98; 95%CI, 0.42-2.28; I 2 = 14.2%), myocardial infarction (OR, 0.84; 95%CI, 0.65-1.08; I 2 = 1.4%) or coronary revascularization (OR, 0.64; 95%CI, 0.28-1.42; I 2 = 49.3%). However, patients treated with colchicine had a lower risk of stroke (OR, 0.33; 95%CI, 0.15-0.72; I 2 = 0%).","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42677064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiencia inicial de trombectom�a con FlowTriever en embolia aguda de pulm�n Flowtriever血栓栓塞治疗急性肺栓塞的初步经验
IF 1.4 Q2 Medicine Pub Date : 2022-12-23 DOI: 10.24875/recic.m22000354
Pablo Salinas, M. Vázquez-Álvarez, Alfonso Jurado-Román, Sílvio Leal y, Mike Huanca
{"title":"Experiencia inicial de trombectom�a con FlowTriever en embolia aguda de pulm�n","authors":"Pablo Salinas, M. Vázquez-Álvarez, Alfonso Jurado-Román, Sílvio Leal y, Mike Huanca","doi":"10.24875/recic.m22000354","DOIUrl":"https://doi.org/10.24875/recic.m22000354","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48030676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primera experiencia en Espa�a con el sistema PiCSO en pacientes con infarto agudo de miocardio 西班牙急性心肌梗塞患者首次使用PICSO系统的经验
IF 1.4 Q2 Medicine Pub Date : 2022-12-23 DOI: 10.24875/recic.m22000355
Pablo Vidal-Calés, Omar Abdul-Jawad Altisent, Francesco Spione, Víctor Arévalos, Manel Sabaté y, S. Brugaletta
{"title":"Primera experiencia en Espa�a con el sistema PiCSO en pacientes con infarto agudo de miocardio","authors":"Pablo Vidal-Calés, Omar Abdul-Jawad Altisent, Francesco Spione, Víctor Arévalos, Manel Sabaté y, S. Brugaletta","doi":"10.24875/recic.m22000355","DOIUrl":"https://doi.org/10.24875/recic.m22000355","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44891537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implante percut�neo de v�lvula a�rtica mediante co-registro FEops HEARTguide 经皮冠状动脉植入术
IF 1.4 Q2 Medicine Pub Date : 2022-12-13 DOI: 10.24875/recic.m22000346
Pablo Antúnez-Muiños, S. López-Tejero, Jesús Herrero Garibi, E. Díaz Peláez, Pedro Luis Sánchez Fernández y, I. Cruz-González
{"title":"Implante percut�neo de v�lvula a�rtica mediante co-registro FEops HEARTguide","authors":"Pablo Antúnez-Muiños, S. López-Tejero, Jesús Herrero Garibi, E. Díaz Peláez, Pedro Luis Sánchez Fernández y, I. Cruz-González","doi":"10.24875/recic.m22000346","DOIUrl":"https://doi.org/10.24875/recic.m22000346","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46110778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alta tasa de struts no cubiertos en stents de �ltima generaci�n con pol�mero persistente, absorbible o sin pol�mero a un mes del implante 植入后一个月内具有持续、可吸收或无聚合物的最新一代支架中未覆盖的高支架率
IF 1.4 Q2 Medicine Pub Date : 2022-12-07 DOI: 10.24875/recic.m22000340
Alicia Calvo-Fernández, Josep Gómez-Lara, Roberto Elosua, Xavier Durán, H. Cubero-Gallego, Helena Tizón-Marcos, N. Salvatella, Alejandro Negrete, Raúl Millán, Consol Ivern, José Luis Díez, Andrea Sánchez-Carpintero, Núria Farré, José M. de la Torre Hernández y, B. Vaquerizo
{"title":"Alta tasa de struts no cubiertos en stents de �ltima generaci�n con pol�mero persistente, absorbible o sin pol�mero a un mes del implante","authors":"Alicia Calvo-Fernández, Josep Gómez-Lara, Roberto Elosua, Xavier Durán, H. Cubero-Gallego, Helena Tizón-Marcos, N. Salvatella, Alejandro Negrete, Raúl Millán, Consol Ivern, José Luis Díez, Andrea Sánchez-Carpintero, Núria Farré, José M. de la Torre Hernández y, B. Vaquerizo","doi":"10.24875/recic.m22000340","DOIUrl":"https://doi.org/10.24875/recic.m22000340","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2022-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48945297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
REC Interventional Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1